BC
RMD icon

Bayforest Capital’s ResMed RMD Stock Holding History

Bayforest Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-350
Closed -$95.8K – 926
2025
Q3 		$95.8K Sell
350
-2,109
-86% -$576K 0.05% 529
2025
Q2 		$634K Buy
2,459
+1,932
+367% +$461K 0.28% 110
2025
Q1 		$118K Sell
527
-333
-39% -$77.7K 0.05% 465
2024
Q4 		$197K Buy
+860
New +$207K 0.25% 138

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bayforest Capital's RMD Position: Q4 2025 in Review

Bayforest Capital sold out of ResMed (RMD) in Q4 2025, closing a stake of 350 shares — an estimated $95.8K sold.

Bayforest Capital first reported a position in RMD in Q4 2024 and held it in 4 quarters. The position peaked at $634K in Q2 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Bayforest Capital reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Bayforest Capital sold 350 ResMed shares in Q4 2025, an estimated $95.8K.
  • Bayforest Capital first reported a position in ResMed in Q4 2024 and held it in 4 quarters.
  • Bayforest Capital's ResMed position peaked at $634K in Q2 2025.
  • 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Bayforest Capital's 13F filing for Q4 2025, filed 27 Jan 2026.